The IL-6 content was twice as high in the severe COVID-19 patients’ EVs compared to the HC EVs (p = 0.0451), and also compared to mild and moderate COVID-19 patients (p = 0.0186, p = 0.0426, respectively) (Figure 6; Supplementary Figure SM1e–g). This evidence concerns the gene IL6 and COVID-19.